CAMARA, B.; BOGNINI, J. D.; NAKAKANA, U. N.; SOME, A. M.; JAGNE, I.; TAHITA, M. C.; BELOUM, N.; SILLAH, F.; DANSO, M.; JONES, J. C.; GRAVES, S.; GETANDA, P.; ROUAMBA, T.; NDURE, E.; FRANCK, H. S.; EDMOND, S. Y.; NJIE, Y.; DONDEH, B. L.; WILFRIED, N. G. J.; BOJANG, A.; ZAKARIA, G.; BOTTOMLEY, C.; D’ALESSANDRO, U.; TINTO, H.; ROCA, A. Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase iii double-blind randomized clinical trial (PregnAnZI-2 trial). International Journal of Clinical Trials, [S. l.], v. 9, n. 1, p. 34–44, 2022. DOI: 10.18203/2349-3259.ijct20220110. Disponível em: https://www.ijclinicaltrials.com/index.php/ijct/article/view/570. Acesso em: 22 feb. 2026.